Stock listing
NASDAQ:NTRB Nutriband Inc. Stock
Home listing (NASDAQ) of Nutriband Inc.
Follow Nutriband Inc. into a list and get an email when it puts out news.
Share price · NASDAQ:NTRB
$4.92 USD +0.10 (+2.1%)
Close on Nov 20, 2026
- Day range
- $4.84 – $5.22 USDNov 20, 2026
- Volume
- 7,026 sharesNov 20, 2026
- Market cap
- $59.81M USDAt the close on Nov 20, 2026 · price × 12.16M shares outstanding
- 52-week range
- $2.80 – $9.19 USDLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
- Traded on an average day
- $488,675 USDMedian day 35,721 shares · last 3 months, Aug 20, 2026 – Nov 20, 2026

Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| NASDAQ:NTRB · Home | $4.92 USD | +0.10 (+2.1%) | 7,026 | $4.95 | $5.224 | $4.838 | $4.82 | Close on Nov 20, 2026 |
| Frankfurt:9WV | €4.34 EUR | -0.16 (-3.6%) | — | €4.26 | €4.34 | €4.26 | €4.50 | Close on Nov 20, 2026 |
Daily closes
Last 3 months, Aug 20, 2026 – Nov 20, 2026 · NASDAQ:NTRB · USD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $4.92 | +0.10 | +2.1% | $4.95 | $5.224 | $4.838 | 7,026 | |
| $4.82 | -0.77 | -13.8% | $5.47 | $5.47 | $4.795 | 28,185 | |
| $5.59 | -0.22 | -3.8% | $5.60 | $5.785 | $5.41 | 20,575 | |
| $5.81 | -0.29 | -4.8% | $6.04 | $6.04 | $5.52 | 25,415 | |
| $6.10 | +0.13 | +2.2% | $5.87 | $6.24 | $5.80 | 28,925 | |
| $5.97 | +0.03 | +0.5% | $5.838 | $6.045 | $5.838 | 21,448 | |
| $5.94 | +0.18 | +3.1% | $5.56 | $6.00 | $5.56 | 7,583 | |
| $5.76 | -0.20 | -3.4% | $5.86 | $5.99 | $5.66 | 6,908 | |
| $5.96 | +0.41 | +7.4% | $5.47 | $5.99 | $5.47 | 20,336 | |
| $5.55 | -0.025 | -0.4% | $5.46 | $5.79 | $5.41 | 13,347 | |
| $5.575 | -0.505 | -8.3% | $5.95 | $5.95 | $5.28 | 35,082 | |
| $6.08 | -0.21 | -3.3% | $6.19 | $6.319 | $6.00 | 24,771 | |
| $6.29 | -0.12 | -1.9% | $6.005 | $6.515 | $6.005 | 17,886 | |
| $6.41 | +0.11 | +1.7% | $6.30 | $6.495 | $6.13 | 14,741 | |
| $6.30 | -0.34 | -5.1% | $6.44 | $6.44 | $6.20 | 22,233 | |
| $6.64 | +0.24 | +3.7% | $6.50 | $6.655 | $6.35 | 12,535 | |
| $6.40 | +0.45 | +7.6% | $6.00 | $6.41 | $5.99 | 71,074 | |
| $5.95 | -0.02 | -0.3% | $6.05 | $6.05 | $5.79 | 11,707 | |
| $5.97 | +0.21 | +3.6% | $5.69 | $6.32 | $5.69 | 26,642 | |
| $5.76 | -0.05 | -0.9% | $5.94 | $5.94 | $5.705 | 6,783 | |
| $5.81 | -0.33 | -5.4% | $6.202 | $6.202 | $5.81 | 16,711 | |
| $6.14 | +0.29 | +5.0% | $5.85 | $6.23 | $5.80 | 22,076 | |
| $5.85 | -0.15 | -2.5% | $5.968 | $6.05 | $5.80 | 16,676 | |
| $6.00 | -0.22 | -3.5% | $6.23 | $6.295 | $5.65 | 79,243 | |
| $6.22 | -0.05 | -0.8% | $6.25 | $6.526 | $6.00 | 27,919 | |
| $6.27 | -0.05 | -0.8% | $6.30 | $6.799 | $6.25 | 70,180 | |
| $6.32 | -0.20 | -3.1% | $6.50 | $6.641 | $6.303 | 51,699 | |
| $6.52 | +0.67 | +11.5% | $5.89 | $6.80 | $5.89 | 69,181 | |
| $5.85 | -0.80 | -12.0% | $6.57 | $6.57 | $5.85 | 15,559 | |
| $6.65 | +0.60 | +9.9% | $6.00 | $6.82 | $5.70 | 45,139 | |
| $6.05 | -0.705 | -10.4% | $6.75 | $6.75 | $6.03 | 35,721 | |
| $6.755 | +0.075 | +1.1% | $6.58 | $7.10 | $6.58 | 10,224 | |
| $6.68 | -0.79 | -10.6% | $7.44 | $7.44 | $6.545 | 87,019 | |
| $7.47 | +0.19 | +2.6% | $7.24 | $7.65 | $7.23 | 19,475 | |
| $7.28 | -0.08 | -1.1% | $7.46 | $7.857 | $7.25 | 47,045 | |
| $7.36 | -0.16 | -2.1% | $7.52 | $7.693 | $7.28 | 42,174 | |
| $7.52 | -0.73 | -8.8% | $8.25 | $8.44 | $7.41 | 147,736 | |
| $8.25 | +0.02 | +0.2% | $8.31 | $8.57 | $8.03 | 140,525 | |
| $8.23 | +0.23 | +2.9% | $7.99 | $8.99 | $7.99 | 284,818 | |
| $8.00 | -0.99 | -11.0% | $9.09 | $9.185 | $7.10 | 409,989 | |
| $8.99 | +1.64 | +22.3% | $7.35 | $9.00 | $7.35 | 387,875 | |
| $7.35 | +0.59 | +8.7% | $6.75 | $7.50 | $6.56 | 129,731 | |
| $6.76 | -1.01 | -13.0% | $7.775 | $7.875 | $6.66 | 319,603 | |
| $7.77 | -0.36 | -4.4% | $8.21 | $8.55 | $7.30 | 135,104 | |
| $8.13 | +0.48 | +6.3% | $7.66 | $8.13 | $7.03 | 110,513 | |
| $7.65 | +0.61 | +8.7% | $7.11 | $7.66 | $6.94 | 102,847 | |
| $7.04 | +0.22 | +3.2% | $6.87 | $7.05 | $6.69 | 44,731 | |
| $6.82 | -0.105 | -1.5% | $6.85 | $7.05 | $6.72 | 45,558 | |
| $6.925 | -0.035 | -0.5% | $6.92 | $7.04 | $6.521 | 108,626 | |
| $6.96 | +0.88 | +14.5% | $6.18 | $6.97 | $6.09 | 99,826 | |
| $6.08 | +0.28 | +4.8% | $5.76 | $6.70 | $5.63 | 112,107 | |
| $5.80 | -0.30 | -4.9% | $6.15 | $6.15 | $5.61 | 39,044 | |
| $6.10 | +0.13 | +2.2% | $6.08 | $6.466 | $5.46 | 109,694 | |
| $5.97 | +0.34 | +6.0% | $5.66 | $6.07 | $5.17 | 96,192 | |
| $5.63 | +0.93 | +19.8% | $4.72 | $5.92 | $4.72 | 170,530 | |
| $4.70 | +0.355 | +8.2% | $4.53 | $4.79 | $4.50 | 29,310 | |
| $4.345 | -0.022 | -0.5% | $4.33 | $4.48 | $4.27 | 18,657 | |
| $4.367 | -0.093 | -2.1% | $4.46 | $4.46 | $4.22 | 25,818 | |
| $4.46 | -0.16 | -3.5% | $4.66 | $4.725 | $4.43 | 6,773 | |
| $4.62 | +0.12 | +2.7% | $4.45 | $4.68 | $4.335 | 12,956 | |
| $4.50 | -0.33 | -6.8% | $4.74 | $4.80 | $4.162 | 61,455 | |
| $4.83 | -0.28 | -5.5% | $5.05 | $5.288 | $4.62 | 37,720 | |
| $5.11 | +0.444 | +9.5% | $4.97 | $5.66 | $4.70 | 257,022 | |
| $4.666 | +0.851 | +22.3% | $3.88 | $4.75 | $3.865 | 67,532 | |
| $3.815 | +0.265 | +7.5% | $3.60 | $3.855 | $3.42 | 18,487 |
- Ticker
- NASDAQ:NTRB
- Asset type
- Stock
- Exchange
- NASDAQ
- Currency
- USD
What changed lately
Latest news release · Nov 17, 2026
Nutriband Announces USPTO Notice of Allowance for Commercial Brand Name Trademarks for Its Abuse-Deterrent Fentanyl Transdermal System
Latest news
Nutriband Announces USPTO Notice of Allowance for Commercial Brand Name Trademarks for Its Abuse-Deterrent Fentanyl Transdermal System
Nov 17, 2026
Closed $5.59 (-3.8%) on Nov 17, 2026
Nutriband Inc. announces exercise of warrants at $6.43 for Gross Proceeds of $1,753,274
Oct 13, 2026
Closed $6.52 (+11.5%) on Oct 13, 2026
Nutriband Files New Patent Application to Strengthen Intellectual Property Protection of Its Transdermal Abuse Deterrent Technology
Oct 8, 2026
Closed $6.05 (-10.4%) on Oct 8, 2026
Nutriband Marks Five Years on Nasdaq – CEO Letter to Shareholders
Oct 1, 2026
Closed $7.28 (-1.1%) on Oct 2, 2026
Nutriband CEO Gareth Sheridan Featured in New Nick Shirley Documentary Confronting America's Opioid Crisis
Sep 29, 2026
Closed $8.25 (+0.2%) on Sep 29, 2026
Nutriband Appoints Decorated Navy SEAL and Veterans Health Advocate Robert J. O'Neill to Advisory Board
Sep 25, 2026
Closed $8.00 (-11.0%) on Sep 25, 2026
Nutriband Confirms Warrants Will Expire September 30 Without Extension or Repricing
Sep 22, 2026
Closed $6.76 (-13.0%) on Sep 22, 2026
Nutriband CEO, Gareth Sheridan to Attend the Nasdaq Life Sciences Advisory Board (LaB) Biotech Summit
Sep 9, 2026
Closed $5.80 (-4.9%) on Sep 9, 2026
Nutriband Receives USPTO Notice of Publication of Commercial Brand Name Trademarks for Its Abuse Deterrent Fentanyl Patch
Sep 8, 2026
Closed $6.10 (+2.2%) on Sep 8, 2026
Nutriband CEO, Gareth Sheridan to Present at the 2026 Georgia Life Sciences Summit as Part of the CEO Spotlight
Aug 13, 2026
Closed $3.19 (+3.7%) on Aug 13, 2026
Nutriband Inc. on 6ix
- News releases
- 23 in the last 12 months · 119 in all · newest Nov 17, 2026 · oldest 2020
- Decks
- 1 deck · latest 2023
Where Nutriband Inc. is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| NASDAQ:NTRB · Home listing · This page | NASDAQ | United States | USD |
| BOATS:NTRB | BOATS | United States | USD |
| Frankfurt:9WV | Frankfurt | Germany | EUR |
Valuation
Statements: 4 quarters to Jul 31, 2026 · price Nov 20, 2026
- Enterprise value
- $56.38M USD
- P/E
- Loss
- EV/sales
- 34.9×
- EV/EBITDA
- No depreciation figure on 6ix yet
- Price/book
- 11.2×
- Gross margin
- 33.1%
- Operating margin
- −435.6%
- Net margin
- −430.4%
- Debt to equity
- 0.0×
- Beta vs S&P 500
- 0.96
Team and board
Officers
| Officer | Role |
|---|---|
| Gareth Sheridan | Founder and CEO |
| Gerald Goodman | CFO |
| Alan Smith | COO, President of 4P Therapeutics |
| Michael Myer | President Pocono Pharmaceutical |
| Serguei Melnik | Founder and President |
Board
| Director | Role |
|---|---|
| Alesandro Puddu | Member Board of Directors |
| Irina Gram | Member Board of Directors |
| Mark Hamilton | Member Board of Directors |
| Radu Bujoreanu | Member Board of Directors |
| Sergei Glinka | Member Board of Directors |
| Serguei Melnik | Founder and President |
| Stefani Mancas | Member Board of Directors |
| Viorica Carlig | Member Board of Directors |
Events
- Next results
- Dec 9, 2026 (expected)
| Quarter | Results | Share move |
|---|---|---|
| Q2 2027 | Sep 4, 2026 | +8.3% |
| Q1 2027 | May 1, 2026 | −4.3% |
| Q4 2026 | Apr 29, 2026 · After close | +2.0% |
| Q3 2026 | Dec 11, 2025 · Before open | +1.6% |
| Q2 2026 | Sep 9, 2025 · After close | −1.3% |
| Q1 2026 | May 30, 2025 · After close | +24.8% |
| Q4 2025 | Apr 28, 2025 · After close | −2.7% |
| Q3 2025 | Dec 10, 2024 · After close | −15.3% |
| Q2 2025 | Sep 3, 2024 · After close | −9.6% |
| Q1 2025 | May 1, 2024 · Before open | +1.2% |
All 20 quarters
| Quarter | Results | Share move |
|---|---|---|
| Q4 2024 | Apr 30, 2024 · Before open | +1.2% |
| Q3 2024 | Dec 13, 2023 · Before open | +4.7% |
| Q2 2024 | Sep 11, 2023 · Before open | +8.8% |
| Q1 2024 | Jun 9, 2023 · After close | +8.3% |
| Q4 2023 | Apr 26, 2023 · Before open | −3.5% |
| Q3 2023 | Dec 2, 2022 · After close | −3.5% |
| Q2 2023 | Sep 8, 2022 · Before open | +5.9% |
| Q1 2023 | May 31, 2022 · After close | −10.2% |
| Q4 2022 | Apr 29, 2022 · Before open | −7.7% |
| Q3 2022 | Dec 14, 2021 · After close | −2.3% |
Decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| Investor Presentation (2023) | Investor deck | 25 slides | 2023 |
Financings
| Raise | Date |
|---|---|
| Warrant exercise of warrants Closed: US$5.31M raised · Warrants at US$6.43 Use of proceeds: Remaining clinical development of AVERSA Fentanyl and submission of its NDA with the FDA for marketing approval | Sep 3, 2025 |
Open Financings · Read by 6ix AI from the company's releases
Financials
Annual, in USD
Income statement
| Line | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 2.04M | 2.14M | 2.09M | 2.08M | 1.42M | 943.7K | 119.4K | 245.3K | ||
| Cost of revenue | 1.47M | 1.40M | 1.22M | 1.33M | 917.8K | 627.4K | 549.1K | 288.3K | ||
| Gross profit | 566.3K | 743.3K | 862.1K | 750.4K | 554.3K | 316.2K | -429.7K | -43.0K | ||
| Research and development | 1.89M | 3.12M | 1.96M | 982.2K | 411.4K | |||||
| Selling, general and administrative | 6.99M | 4.31M | 3.77M | 3.92M | 4.02M | 2.91M | 1.79M | 3.29M | 171.9K | 151.3K |
| Operating income | -8.32M | -10.3M | -4.87M | -4.48M | -6.11M | -2.60M | -1.97M | -3.33M | -2.67M | -151.3K |
| Depreciation and amortization | 193.8K | 285.1K | 287.7K | 330.1K | 308.7K | 160.1K | 72.2K | 37.0K | 0 | |
| EBITDA | -8.12M | -10.00M | -4.58M | -4.15M | -5.80M | -2.44M | -1.90M | -3.29M | -2.67M | |
| Interest expense | 22.5K | 21.4K | 75.8K | 8.29K | 118.4K | 280.7K | 73.4K | |||
| Income before tax | -8.23M | -10.5M | -5.49M | -4.48M | -6.18M | -2.93M | -2.72M | -3.33M | -2.67M | |
| Net income | -8.23M | -10.5M | -5.49M | -4.48M | -6.18M | -2.93M | -2.72M | -3.33M | -2.67M | -151.3K |
| Earnings per share, basic | -2.58 | -0.99 | -0.69 | -0.53 | -0.80 | -0.51 | -0.50 | -0.62 | -0.14 | -0.01 |
| Earnings per share, diluted | -2.58 | -0.99 | -0.69 | -0.53 | -0.80 | -0.51 | -0.50 | -0.62 | -0.14 | -0.01 |
Balance sheet
| Line | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 4.57M | 4.31M | 492.9K | 1.99M | 4.89M | 152.0K | 10.2K | 474.7K | 27.1K | |
| Receivables | 118.4K | 73.8K | 148.6K | 113.0K | 71.4K | 109.3K | 12.8K | 13.1K | ||
| Inventory | 118.0K | 212.0K | 168.6K | 229.3K | 131.6K | 52.8K | 4.13K | 8.05K | ||
| Current assets | 4.99M | 4.79M | 1.02M | 2.69M | 5.47M | 314.2K | 43.2K | 590.5K | 164.9K | 37.7K |
| Property, plant and equipment | 567.3K | 695.1K | 774.9K | 897.7K | 979.3K | 1.08M | 111.0K | 146.1K | 146.1K | |
| Goodwill | 1.72M | 1.72M | 5.02M | 5.02M | 5.35M | 7.53M | 1.72M | 1.72M | ||
| Total assets | 7.55M | 7.47M | 7.52M | 9.46M | 12.7M | 9.93M | 2.20M | 2.81M | 164.9K | 37.7K |
| Current liabilities | 784.3K | 982.8K | 999.1K | 748.6K | 779.3K | 2.57M | 2.02M | 403.0K | 43.4K | 14.6K |
| Total debt | 0 | 16.1K | 10.5K | |||||||
| Total liabilities | 868.4K | 1.04M | 1.08M | 883.4K | 880.4K | 2.82M | 2.02M | 14.6K | ||
| Shareholders' equity | 6.68M | 6.43M | 6.44M | 8.57M | 11.9M | 7.11M | 175.4K | 2.40M | 121.5K | 23.1K |
| Shares outstanding | 12.2M | 11.1M | 8.86M | 7.83M | 9.15M | 6.26M | 5.44M | 5.42M | 20.9M | 15.6M |
Cash flow
| Line | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operations | -5.13M | -4.63M | -3.53M | -2.99M | -2.81M | -297.1K | -894.5K | -1.11M | -92.9K | -147.9K |
| Capital spending | -5.32K | -92.0K | -51.8K | -79.3K | -81.6K | -4.16K | ||||
| Free cash flow | -5.14M | -4.72M | -3.58M | -3.07M | -2.89M | -1.11M | ||||
| Cash from investing | -5.32K | -92.0K | -51.8K | -79.3K | -81.6K | 67.0K | -404.2K | |||
| Cash from financing | 5.40M | 8.54M | 2.09M | 160.1K | 7.63M | 371.9K | 430.3K | 1.98M | 65.8K | 174.9K |
| Change in cash | 263.1K | 3.82M | -1.49M | -2.91M | 4.74M | 141.8K | -464.5K | 474.7K | -27.1K | 27.0K |
Filings
| Filing | Date | Type | Filed with |
|---|---|---|---|
| 25-NSE | Sep 30, 2026 | Other filings | SEC |
| 8-K · Current report | Sep 23, 2026 | Current report | SEC |
| SCHEDULE 13D/A · Big-stake notice, amended | Sep 15, 2026 | Big-stake notice | SEC |
| 10-Q · Quarterly report | Sep 4, 2026 | Quarterly report | SEC |
| 8-K · Current report | Jun 22, 2026 | Material contract | SEC |
| 10-Q · Quarterly report | Jun 11, 2026 | Quarterly report | SEC |
| 10-K/A · Annual report, amended | May 18, 2026 | Annual report | SEC |
| 10-K · Annual report | Apr 29, 2026 | Annual report | SEC |
| 8-K · Current report | Apr 7, 2026 | Current report | SEC |
| 8-K · Current report | Feb 13, 2026 | Current report | SEC |
Show 200 filings
| Filing | Date | Type | Filed with |
|---|---|---|---|
| 424B3 · Prospectus | Feb 12, 2026 | Offer document | SEC |
| 8-K · Current report | Feb 3, 2026 | Meeting outcome | SEC |
| 8-K · Current report | Dec 30, 2025 | Current report | SEC |
| DEF 14A · Proxy statement | Dec 19, 2025 | Meeting notice | SEC |
| 10-Q · Quarterly report | Dec 10, 2025 | Quarterly report | SEC |
| 5 · Annual statement of ownership | Nov 25, 2025 | Insider trade | SEC |
| 8-K · Current report | Oct 28, 2025 | Current report | SEC |
| 5 · Annual statement of ownership | Oct 21, 2025 | Insider trade | SEC |
| 424B3 · Prospectus | Oct 20, 2025 | Offer document | SEC |
| 10-Q · Quarterly report | Sep 9, 2025 | Quarterly report | SEC |
| 8-K · Current report | Sep 3, 2025 | Current report | SEC |
| 8-K · Current report | Aug 7, 2025 | Financing | SEC |
| 8-K · Current report | Jul 15, 2025 | Current report | SEC |
| 424B4 · Prospectus | Jul 7, 2025 | Offer document | SEC |
| EFFECT · Notice that a registration is effective | Jul 7, 2025 | Other filings | SEC |
| POS AM · Amendment to an effective registration | Jul 3, 2025 | Offer document | SEC |
| POS AM · Amendment to an effective registration | Jun 20, 2025 | Offer document | SEC |
| 10-Q · Quarterly report | May 30, 2025 | Quarterly report | SEC |
| 10-K/A · Annual report, amended | May 13, 2025 | Annual report | SEC |
| 10-K · Annual report | Apr 28, 2025 | Annual report | SEC |
| 8-K · Current report | Apr 9, 2025 | Current report | SEC |
| SCHEDULE 13D · Big-stake notice | Mar 13, 2025 | Big-stake notice | SEC |
| SCHEDULE 13D · Big-stake notice | Mar 13, 2025 | Big-stake notice | SEC |
| 8-K · Current report | Feb 13, 2025 | Current report | SEC |
| 8-K · Current report | Feb 12, 2025 | Current report | SEC |
| 8-K · Current report | Jan 29, 2025 | Meeting outcome | SEC |
| 8-K · Current report | Dec 30, 2024 | Current report | SEC |
| DEF 14A · Proxy statement | Dec 16, 2024 | Meeting notice | SEC |
| 10-Q · Quarterly report | Dec 3, 2024 | Quarterly report | SEC |
| 4 · Change in ownership | Dec 2, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Nov 29, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Nov 29, 2024 | Insider trade | SEC |
| 8-K · Current report | Oct 31, 2024 | Current report | SEC |
| SC 13D/A · Big-stake notice, amended | Sep 19, 2024 | Big-stake notice | SEC |
| 8-K · Current report | Sep 18, 2024 | Current report | SEC |
| 10-Q · Quarterly report | Sep 3, 2024 | Quarterly report | SEC |
| 424B4 · Prospectus | Jul 26, 2024 | Offer document | SEC |
| EFFECT · Notice that a registration is effective | Jul 26, 2024 | Other filings | SEC |
| POS AM · Amendment to an effective registration | Jul 22, 2024 | Offer document | SEC |
| POS AM · Amendment to an effective registration | Jul 3, 2024 | Offer document | SEC |
| 8-K/A · Current report, amended | Jun 3, 2024 | Financing | SEC |
| 10-Q · Quarterly report | May 31, 2024 | Quarterly report | SEC |
| 8-K · Current report | May 20, 2024 | Financing | SEC |
| 8-K · Current report | May 16, 2024 | Management or board change | SEC |
| 10-K · Annual report | Apr 30, 2024 | Annual report | SEC |
| NT 10-K · Late filing notice | Apr 30, 2024 | Explanation request | SEC |
| 8-K · Current report | Apr 23, 2024 | Material contract | SEC |
| 8-K · Current report | Mar 28, 2024 | Financing | SEC |
| 5 · Annual statement of ownership | Mar 25, 2024 | Insider trade | SEC |
| 5 · Annual statement of ownership | Mar 25, 2024 | Insider trade | SEC |
| 5 · Annual statement of ownership | Mar 25, 2024 | Insider trade | SEC |
| SC 13G · Big-stake notice | Feb 13, 2024 | Big-stake notice | SEC |
| SC 13G · Big-stake notice | Feb 12, 2024 | Big-stake notice | SEC |
| 8-K · Current report | Jan 25, 2024 | Meeting outcome | SEC |
| SC 13D · Big-stake notice | Jan 23, 2024 | Big-stake notice | SEC |
| 8-K · Current report | Jan 11, 2024 | Current report | SEC |
| 8-K · Current report | Dec 29, 2023 | Financing | SEC |
| DEF 14A · Proxy statement | Dec 14, 2023 | Meeting notice | SEC |
| 10-Q · Quarterly report | Dec 12, 2023 | Quarterly report | SEC |
| 10-Q · Quarterly report | Sep 8, 2023 | Quarterly report | SEC |
| RW · Request to withdraw a registration | Jul 19, 2023 | Other filings | SEC |
| 8-K · Current report | Jul 14, 2023 | Material contract | SEC |
| RW · Request to withdraw a registration | Jul 14, 2023 | Other filings | SEC |
| S-1/A · Registration statement, amended | Jul 5, 2023 | Offer document | SEC |
| S-1/A · Registration statement, amended | Jun 23, 2023 | Offer document | SEC |
| UPLOAD · Letter from the SEC | Jun 22, 2023 | Other filings | SEC |
| 8-K/A · Current report, amended | Jun 21, 2023 | Current report | SEC |
| 10-Q · Quarterly report | Jun 9, 2023 | Quarterly report | SEC |
| CORRESP · Letter to the SEC | Jun 9, 2023 | Other filings | SEC |
| CORRESP · Letter to the SEC | May 31, 2023 | Other filings | SEC |
| UPLOAD · Letter from the SEC | May 31, 2023 | Other filings | SEC |
| CORRESP · Letter to the SEC | May 25, 2023 | Other filings | SEC |
| DEL AM | May 11, 2023 | Other filings | SEC |
| S-1 · Registration statement | May 9, 2023 | Offer document | SEC |
| 10-K · Annual report | Apr 26, 2023 | Annual report | SEC |
| CORRESP · Letter to the SEC | Apr 6, 2023 | Other filings | SEC |
| 8-K · Current report | Mar 29, 2023 | Current report | SEC |
| UPLOAD · Letter from the SEC | Mar 24, 2023 | Other filings | SEC |
| 4 · Change in ownership | Mar 8, 2023 | Insider trade | SEC |
| CORRESP · Letter to the SEC | Feb 27, 2023 | Other filings | SEC |
| UPLOAD · Letter from the SEC | Feb 13, 2023 | Other filings | SEC |
| 8-K · Current report | Jan 5, 2023 | Current report | SEC |
| 8-K · Current report | Dec 30, 2022 | Management or board change | SEC |
| 424B3 · Prospectus | Dec 30, 2022 | Offer document | SEC |
| 10-Q · Quarterly report | Dec 2, 2022 | Quarterly report | SEC |
| DEF 14A · Proxy statement | Oct 31, 2022 | Meeting notice | SEC |
| 5/A · Annual statement of ownership, amended | Oct 25, 2022 | Insider trade | SEC |
| 5/A · Annual statement of ownership, amended | Oct 25, 2022 | Insider trade | SEC |
| S-8 POS | Oct 11, 2022 | Offer document | SEC |
| 424B3 · Prospectus | Oct 6, 2022 | Offer document | SEC |
| 8-K · Current report | Oct 6, 2022 | Current report | SEC |
| 10-Q · Quarterly report | Sep 7, 2022 | Quarterly report | SEC |
| 8-K · Current report | Aug 19, 2022 | Management or board change | SEC |
| 8-K · Current report | Aug 10, 2022 | Current report | SEC |
| 8-K · Current report | Aug 1, 2022 | Current report | SEC |
| 8-K · Current report | Jul 27, 2022 | Current report | SEC |
| 8-K · Current report | Jul 26, 2022 | Current report | SEC |
| 8-K · Current report | Jul 15, 2022 | Current report | SEC |
| 424B4 · Prospectus | Jul 8, 2022 | Offer document | SEC |
| 4 · Change in ownership | Jul 7, 2022 | Insider trade | SEC |
| 5 · Annual statement of ownership | Jul 5, 2022 | Insider trade | SEC |
| 5 · Annual statement of ownership | Jul 5, 2022 | Insider trade | SEC |
| 5 · Annual statement of ownership | Jul 5, 2022 | Insider trade | SEC |
| EFFECT · Notice that a registration is effective | Jul 1, 2022 | Other filings | SEC |
| POS AM · Amendment to an effective registration | Jun 28, 2022 | Offer document | SEC |
| POS AM · Amendment to an effective registration | Jun 17, 2022 | Offer document | SEC |
| 10-Q · Quarterly report | May 31, 2022 | Quarterly report | SEC |
| POS AM · Amendment to an effective registration | May 13, 2022 | Offer document | SEC |
| 10-K · Annual report | Apr 28, 2022 | Annual report | SEC |
| 424B3 · Prospectus | Feb 28, 2022 | Offer document | SEC |
| 4/A · Change in ownership, amended | Feb 25, 2022 | Insider trade | SEC |
| 4/A · Change in ownership, amended | Feb 24, 2022 | Insider trade | SEC |
| 4 · Change in ownership | Feb 24, 2022 | Insider trade | SEC |
| 4 · Change in ownership | Feb 10, 2022 | Insider trade | SEC |
| 8-K · Current report | Jan 31, 2022 | Current report | SEC |
| 8-K · Current report | Jan 27, 2022 | Management or board change | SEC |
| 8-K · Current report | Jan 10, 2022 | Current report | SEC |
| 8-K · Current report | Jan 3, 2022 | Current report | SEC |
| 424B3 · Prospectus | Jan 3, 2022 | Offer document | SEC |
| 8-K · Current report | Dec 30, 2021 | Current report | SEC |
| 10-Q · Quarterly report | Dec 14, 2021 | Quarterly report | SEC |
| DEF 14A · Proxy statement | Dec 9, 2021 | Meeting notice | SEC |
| 424B3 · Prospectus | Nov 15, 2021 | Offer document | SEC |
| 424B3 · Prospectus | Nov 12, 2021 | Offer document | SEC |
| S-8 · Registration statement for employee plans | Nov 5, 2021 | Offer document | SEC |
| EFFECT · Notice that a registration is effective | Oct 29, 2021 | Other filings | SEC |
| POS AM · Amendment to an effective registration | Oct 21, 2021 | Offer document | SEC |
| 8-K · Current report | Oct 12, 2021 | Material contract | SEC |
| 8-K · Current report | Oct 8, 2021 | Management or board change | SEC |
| 424B4 · Prospectus | Oct 5, 2021 | Offer document | SEC |
| EFFECT · Notice that a registration is effective | Oct 4, 2021 | Other filings | SEC |
| 8-K · Current report | Oct 1, 2021 | Current report | SEC |
| CERT · Exchange's certificate of listing | Oct 1, 2021 | Other filings | SEC |
| CORRESP · Letter to the SEC | Sep 30, 2021 | Other filings | SEC |
| CORRESP · Letter to the SEC | Sep 30, 2021 | Other filings | SEC |
| S-1/A · Registration statement, amended | Sep 30, 2021 | Offer document | SEC |
| S-1/A · Registration statement, amended | Sep 29, 2021 | Offer document | SEC |
| 8-A12B · Registration of shares for listing on an exchange | Sep 28, 2021 | Other filings | SEC |
| S-1 · Registration statement | Sep 27, 2021 | Offer document | SEC |
| 10-Q · Quarterly report | Sep 3, 2021 | Quarterly report | SEC |
| 8-K · Current report | Sep 1, 2021 | Material contract | SEC |
| 10-Q · Quarterly report | Jun 14, 2021 | Quarterly report | SEC |
| DRS/A · Draft registration statement, amended | Apr 7, 2021 | Offer document | SEC |
| 10-K · Annual report | Apr 2, 2021 | Annual report | SEC |
| 8-K · Current report | Mar 11, 2021 | Material contract | SEC |
| UPLOAD · Letter from the SEC | Feb 8, 2021 | Other filings | SEC |
| DRS · Draft registration statement | Jan 29, 2021 | Offer document | SEC |
| 8-K/A · Current report, amended | Jan 22, 2021 | Financing | SEC |
| 8-K/A · Current report, amended | Jan 21, 2021 | Financing | SEC |
| 8-K · Current report | Jan 21, 2021 | Financing | SEC |
| 424B3 · Prospectus | Jan 19, 2021 | Offer document | SEC |
| 8-K/A · Current report, amended | Jan 11, 2021 | Current report | SEC |
| 10-Q · Quarterly report | Dec 15, 2020 | Quarterly report | SEC |
| DEF 14C | Oct 9, 2020 | Meeting notice | SEC |
| 424B3 · Prospectus | Sep 22, 2020 | Offer document | SEC |
| 10-Q · Quarterly report | Sep 11, 2020 | Quarterly report | SEC |
| 8-K · Current report | Sep 4, 2020 | Material contract | SEC |
| 424B3 · Prospectus | Jul 6, 2020 | Offer document | SEC |
| EFFECT · Notice that a registration is effective | Jun 5, 2020 | Other filings | SEC |
| 10-Q · Quarterly report | Jun 4, 2020 | Quarterly report | SEC |
| CORRESP · Letter to the SEC | Jun 2, 2020 | Other filings | SEC |
| CORRESP · Letter to the SEC | May 28, 2020 | Other filings | SEC |
| S-1/A · Registration statement, amended | May 27, 2020 | Offer document | SEC |
| UPLOAD · Letter from the SEC | May 22, 2020 | Other filings | SEC |
| CORRESP · Letter to the SEC | May 21, 2020 | Other filings | SEC |
| S-1/A · Registration statement, amended | May 18, 2020 | Offer document | SEC |
| UPLOAD · Letter from the SEC | May 14, 2020 | Other filings | SEC |
| S-1 · Registration statement | Apr 16, 2020 | Offer document | SEC |
| 10-K · Annual report | Apr 14, 2020 | Annual report | SEC |
| 8-K · Current report | Apr 3, 2020 | Current report | SEC |
| 8-K · Current report | Mar 19, 2020 | Current report | SEC |
| RW · Request to withdraw a registration | Mar 9, 2020 | Other filings | SEC |
| 8-K · Current report | Feb 21, 2020 | Management or board change | SEC |
| 8-K · Current report | Jan 27, 2020 | Meeting outcome | SEC |
| DEF 14A · Proxy statement | Jan 8, 2020 | Meeting notice | SEC |
| PRE 14A · Preliminary proxy statement | Dec 26, 2019 | Meeting notice | SEC |
| S-1/A · Registration statement, amended | Dec 13, 2019 | Offer document | SEC |
| 10-Q · Quarterly report | Dec 12, 2019 | Quarterly report | SEC |
| S-1/A · Registration statement, amended | Dec 3, 2019 | Offer document | SEC |
| FWP · Free writing prospectus | Nov 26, 2019 | Offer document | SEC |
| S-1/A · Registration statement, amended | Nov 25, 2019 | Offer document | SEC |
| S-1/A · Registration statement, amended | Nov 15, 2019 | Offer document | SEC |
| 8-K · Current report | Nov 4, 2019 | Material contract | SEC |
| S-1/A · Registration statement, amended | Sep 17, 2019 | Offer document | SEC |
| 10-Q · Quarterly report | Sep 12, 2019 | Quarterly report | SEC |
| S-1/A · Registration statement, amended | Aug 30, 2019 | Offer document | SEC |
| S-1/A · Registration statement, amended | Aug 16, 2019 | Offer document | SEC |
| S-1/A · Registration statement, amended | Jul 25, 2019 | Offer document | SEC |
| 8-K · Current report | Jul 22, 2019 | Current report | SEC |
| S-1 · Registration statement | Jun 26, 2019 | Offer document | SEC |
This page holds 200 of 261 filings. Open Filings
Cap table
Built by 6ix from Nutriband Inc.’s releases · as of Sep 4, 2026
- Common shares
- 12,155,683
- Fully diluted
- 12,155,683
Fully diluted
| Line | Shares | As of |
|---|---|---|
| Common shares | 12,155,683 | Sep 4, 2026 |
Warrants and options
| Lot |
|---|
| Warrants · US$6.43 · expiry not stated |
Share count over time
| Count | Shares |
|---|---|
| Sep 4, 2026 | 12,155,683 |
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Michael Davidov Other companies: Thunder Power Holdings, Inc. (Director · Jun 15, 2022 – Jun 15, 2022 · Past); SAIHEAT Limited (Director · Apr 28, 2021 – Apr 28, 2021 · Past) | Director · May 31, 2018 – Jul 31, 2018 · Past |
| Alan Smith | COO, President of 4P Therapeutics · Since at least Oct 28, 2025 |
| Alesandro Puddu | Member Board of Directors · Since at least Nov 18, 2026 |
| Gareth Sheridan | Founder and CEO · Since at least Jan 31, 2025 |
| Gerald Goodman | CFO · Since at least Nov 18, 2026 |
| Irina Gram | Member Board of Directors · Since at least Nov 18, 2026 |
| Jeff Patrick | CSO · Nov 4, 2026 – Nov 18, 2026 · Past |
| Mark Hamilton | Member Board of Directors · Since at least Nov 18, 2026 |
| Michael Myer | President Pocono Pharmaceutical · Since at least Nov 18, 2026 |
| Radu Bujoreanu | Member Board of Directors · Since at least Nov 18, 2026 |
All 16 people
| Person | Seat |
|---|---|
| Sergei Glinka | Member Board of Directors · Since at least Nov 18, 2026 |
| Serguei Melnik | Founder and President · Since at least Jan 31, 2022 |
| Srinvas Nalamachu | Chief Medical Officer · Nov 4, 2026 – Nov 18, 2026 · Past |
| Stefani Mancas | Member Board of Directors · Since at least Nov 18, 2026 |
| Viorica Carlig | Member Board of Directors · Since at least Oct 1, 2026 |
| Vitalie Botgros | Chairman of the BOD, Director · Jan 31, 2017 – Jan 31, 2017 · Past |
Log in to ask 6ix AI your own questions about Nutriband Inc.